Thank you for posting the entire Morningstar review of MYRX. It is conservative and that is a fair way for any of us to look at Myriad Pharma at this point.
I agree that news of positive results in this year will/could give a nice bump. My holding isn't large, but got in at 4.50. I'll add along the way. I'm hoping someday it might feel large when (and if) the PPS reflects positive results.